Document Detail


Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.
MedLine Citation:
PMID:  22228316     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Osteoporosis is increasingly common worldwide and there is a growing concern that the long-term use of antipsychotic medications increases the risk of this disorder. In this review, we consider whether antipsychotics may contribute to the development of osteoporosis through reductions in bone mineral density, discuss the possible mechanisms involved and consider the clinical implications of such a relationship.
METHODS: We searched the literature for studies in this area published between 1966 and 2010 using the Medline and PubMed databases, supplemented by hand searches of retrieved reports.
RESULTS: The available data indicate that statistically significant reductions in bone mineral density are frequently seen in patients prescribed with antipsychotic medications and suggest that there is a higher incidence of clinically significant reductions compared with the normal population.
CONCLUSIONS: Clinicians should be aware for the potential negative effects of antipsychotic medications on bone mineral density, particularly in patients with additional risk factors for osteoporosis. Recommendations regarding routine monitoring of bone mineral density for patients prescribed antipsychotic medications cannot be made on the basis of existing evidence, and more research is required.
Authors:
Matthieu P K Crews; Oliver D Howes
Related Documents :
8769656 - Family violence education in medical school-based residency programs--virginia, 1995.
19356856 - Salerno, saints, and sutton's law: on the origin of europe's "first" medical school.
16563036 - Teens' perceptions about attention deficit/hyperactivity disorder and medications.
16306926 - Risk factors for goiter in primary school girls in qom city of iran.
2620446 - The preschool medical: an evaluation of this examination and its role in child health s...
8208186 - Training for medical teachers: a uk survey, 1993.
Publication Detail:
Type:  Journal Article; Review     Date:  2012-01-09
Journal Detail:
Title:  Human psychopharmacology     Volume:  27     ISSN:  1099-1077     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-01-26     Completed Date:  2012-06-29     Revised Date:  2013-08-15    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  15-23     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Affiliation:
South London and Maudsley NHS Foundation Trust, The Maudsley Hospital, Denmark Hill, London, SE5 8AZ, UK. Matthieu.Crews@slam.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antipsychotic Agents / adverse effects*,  therapeutic use
Bone Density / drug effects*
Drug Monitoring
Humans
Osteoporosis / epidemiology,  etiology*
Risk Factors
Schizophrenia / drug therapy
Grant Support
ID/Acronym/Agency:
MC_U120097115//Medical Research Council
Chemical
Reg. No./Substance:
0/Antipsychotic Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detections of the Neonicotinoid Insecticide Imidacloprid in Surface Waters of Three Agricultural Reg...
Next Document:  White spotting variant mouse as an experimental model for ovarian aging and menopausal biology.